Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RB Health Nordic A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.3% 2.3%   Bankruptcy risk   0.9% 4.2% 2.1% 5.4% 0.7% 0.7% 4.4% 4.0%   Credit score (0-100)   91 49 68 40 95 95 47 50   Credit rating   A BBB A BBB AA AA BBB BBB   Credit limit (mDKK)   12.6 0.0 0.0 0.0 9.9 11.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   869 251 296 301 375 346 346 346   Gross profit   122 44.9 53.5 58.1 71.2 64.4 0.0 0.0   EBITDA   48.8 -2.3 16.2 -4.8 24.3 25.1 0.0 0.0   EBIT   31.8 -2.3 16.2 -4.8 22.8 24.1 0.0 0.0   Pre-tax profit (PTP)   32.7 -4.1 4.6 -7.0 20.3 21.1 0.0 0.0   Net earnings   26.5 -4.1 4.6 -7.0 15.8 15.1 0.0 0.0   Pre-tax profit without non-rec. items   32.7 -2.3 16.2 -4.8 20.3 21.1 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0   Shareholders equity total   124 44.6 52.9 45.6 63.9 77.3 75.4 75.4   Interest-bearing liabilities   120 0.0 0.0 0.0 128 171 0.0 0.0   Balance sheet total (assets)   450 234 301 249 258 310 75.4 75.4   Net Debt   98.0 0.0 0.0 0.0 93.6 139 -67.1 -67.1     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   869 251 296 301 375 346 346 346   Net sales growth   -5.8% -71.1% 18.0% 1.5% 24.8% -7.8% 0.0% 0.0%   Gross profit   122 44.9 53.5 58.1 71.2 64.4 0.0 0.0   Gross profit growth   -66.5% -63.3% 19.3% 8.5% 22.6% -9.5% -100.0% 0.0%   Employees   111 43 46 48 54 52 0 0   Employee growth %   -3.5% -61.3% 7.0% 4.3% 12.5% -3.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   450 234 301 249 258 310 75 75   Balance sheet change%   -9.4% -47.9% 28.2% -17.1% 3.6% 20.1% -75.7% 0.0%   Added value   48.8 -2.3 16.2 -4.8 22.8 25.1 0.0 0.0   Added value %   5.6% -0.9% 5.5% -1.6% 6.1% 7.2% 0.0% 0.0%   Investments   -34 -57 0 0 8 -2 -1 0   Net sales trend   -2.0 -3.0 1.0 2.0 3.0 -1.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 -1.0 1.0 2.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   5.6% -0.9% 5.5% -1.6% 6.5% 7.2% 0.0% 0.0%   EBIT %   3.7% -0.9% 5.5% -1.6% 6.1% 7.0% 0.0% 0.0%   EBIT to gross profit (%)   26.0% -5.1% 30.2% -8.2% 32.0% 37.5% 0.0% 0.0%   Net Earnings %   3.1% -1.6% 1.6% -2.3% 4.2% 4.4% 0.0% 0.0%   Profit before depreciation and extraordinary items %   5.0% -1.6% 1.6% -2.3% 4.6% 4.6% 0.0% 0.0%   Pre tax profit less extraordinaries %   3.8% -0.9% 5.5% -1.6% 5.4% 6.1% 0.0% 0.0%   ROA %   6.9% -0.7% 6.1% -1.7% 12.1% 12.8% 0.0% 0.0%   ROI %   12.8% -1.0% 6.1% -1.7% 13.9% 16.4% 0.0% 0.0%   ROE %   23.9% -4.9% 9.5% -14.2% 28.8% 21.4% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   27.5% 100.0% 100.0% 100.0% 24.8% 25.0% 100.0% 100.0%   Relative indebtedness %   37.3% 0.0% 0.0% 0.0% 51.4% 66.8% 0.0% 0.0%   Relative net indebtedness %   34.7% 0.0% 0.0% 0.0% 42.3% 57.5% -19.4% -19.4%   Net int. bear. debt to EBITDA, %   200.8% 0.0% 0.0% 0.0% 385.9% 553.2% 0.0% 0.0%   Gearing %   97.0% 0.0% 0.0% 0.0% 199.8% 220.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 0.0% 0.0% 0.0% 16.3% 10.2% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 0.0 0.0 0.0 1.1 1.1 0.0 0.0   Current Ratio   1.2 0.0 0.0 0.0 1.3 1.3 0.0 0.0   Cash and cash equivalent   22.2 0.0 0.0 0.0 34.1 32.2 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   44.0 0.0 0.0 0.0 46.9 49.0 0.0 0.0   Trade creditors turnover (days)   77.2 0.0 0.0 0.0 113.4 120.8 0.0 0.0   Current assets / Net sales %   45.2% 0.0% 0.0% 0.0% 66.1% 86.9% 19.4% 19.4%   Net working capital   68.4 0.0 0.0 0.0 55.5 70.4 0.0 0.0   Net working capital %   7.9% 0.0% 0.0% 0.0% 14.8% 20.4% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   8 6 6 6 7 7 0 0   Added value / employee   0 -0 0 -0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -0 0 -0 0 0 0 0   EBIT / employee   0 -0 0 -0 0 0 0 0   Net earnings / employee   0 -0 0 -0 0 0 0 0